Key points are not available for this paper at this time.
Advancements in immunotherapy for recurrent head and neck cancer have necessitated a better understanding of salvage surgical outcomes. This study aimed to determine patterns of failure following salvage head and neck surgery.
Contrera et al. (Tue,) studied this question.